Hydralazine/isosorbide dinitrate
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Hydralazine/isosorbide dinitrate?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Hydralazine/isosorbide dinitrate, sold under the brand name Bidil, is a fixed-dose combination medication used to treat self-identified Black people with congestive heart failure.[1] It is a combination of hydralazine hydrochloride (an arteriolar vasodilator) and isosorbide dinitrate (a nitrate vasodilator).[1][2]
Quick Facts Combination of, Isosorbide dinitrate ...
Combination of | |
---|---|
Isosorbide dinitrate | Vasodilator |
Hydralazine | Antihypertensive |
Clinical data | |
Trade names | Bidil |
License data | |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
ChemSpider |
|
KEGG |
|
CompTox Dashboard (EPA) | |
![]() ![]() |
Close
![]() | The examples and perspective in this article may not represent a worldwide view of the subject. (May 2016) |
The American Food and Drug Administration (FDA) approved this race-specific medication to treat congestive heart failure in specifically self-identified Black patients. It provoked controversy as the first drug approved by the FDA marketed for a single racial-ethnic group.[3]